C. elegans Mutant Identification with a One-Step Whole-Genome-Sequencing and SNP Mapping Strategy

Maria Doitsidou(Columbia University Irving Medical Center), Richard J. Poole(Howard Hughes Medical Institute), Sumeet Sarin(Howard Hughes Medical Institute), Henry Bigelow(Columbia University Irving Medical Center), Oliver Hobert(Howard Hughes Medical Institute)
PLoS ONE
November 8, 2010
Cited by 277Open Access
Full Text

Abstract

Whole-genome sequencing (WGS) is becoming a fast and cost-effective method to pinpoint molecular lesions in mutagenized genetic model systems, such as Caenorhabditis elegans. As mutagenized strains contain a significant mutational load, it is often still necessary to map mutations to a chromosomal interval to elucidate which of the WGS-identified sequence variants is the phenotype-causing one. We describe here our experience in setting up and testing a simple strategy that incorporates a rapid SNP-based mapping step into the WGS procedure. In this strategy, a mutant retrieved from a genetic screen is crossed with a polymorphic C. elegans strain, individual F2 progeny from this cross is selected for the mutant phenotype, the progeny of these F2 animals are pooled and then whole-genome-sequenced. The density of polymorphic SNP markers is decreased in the region of the phenotype-causing sequence variant and therefore enables its identification in the WGS data. As a proof of principle, we use this strategy to identify the molecular lesion in a mutant strain that produces an excess of dopaminergic neurons. We find that the molecular lesion resides in the Pax-6/Eyeless ortholog vab-3. The strategy described here will further reduce the time between mutant isolation and identification of the molecular lesion.


Related Papers

No related papers found

Powered by citation graph analysis